Here, we have demonstrated that for ALT-pathway activity in glioma (and possibly other ALT-cancer types), the proximal genetic causation is ATRX loss, whilst the evolutionary causation can be accumulation of ROS (Fig. 8A). This evidence concerns the gene GPT and glioma.